Jere Bayne is currently a Therapeutic Area Manager at Genentech, a position held since 2020. Prior to this role, Jere served as a Senior Clinical Specialist in Multiple Sclerosis and a Senior Clinical Oncology Specialist, where they promoted Avastin. Jere obtained a degree from Radford University’s College of Business and Economics, completing their studies in 1989.
This person is not in the org chart
This person is not in any teams
This person is not in any offices